ClinicalTrials.gg
Active, not recruitingNCT06729164Updated Aug 28, 2026

Strategic and Interactive Signing Instruction Experiment

An interventional study of Strategic and Interactive Signing Instruction and Business-As-Usual Instruction in Sign Language Skills and Teacher Practice, sponsored by The University of Tennessee, Knoxville. Active, not recruiting at 1 site in United States. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by The University of Tennessee, Knoxville · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
4 Years to 12 Years
Sex
All
01

Study summary

This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.

Read the detailed description

This randomized controlled trial (RCT) examines the effects of the Strategic and Interactive Signing Instruction (SISI) intervention on deaf children's expressive language development in signing (primary) and writing (secondary). The study compares two groups - an intervention group implementing SISI and a control group continuing their usual instructional routines without the intervention.

The intervention group will include approximately 10 teachers, each working with 5-7 deaf children. These classrooms will implement the SISI intervention, which provides structured, language-centered supports designed to strengthen children's signing through explicit modeling, guided practice, and discourse-focused intervention routines. Schools that participated in the 2024-2025 nationwide pre/post study will be included in the intervention group for 2025-2026 if they choose to continue.

The control group will likewise include approximately 10 teachers with 5-7 Deaf children each. These classrooms will continue with their standard practices without the SISI intervention. Schools newly joining the project in 2025-2026 will be assigned to this group.

Child language data will be collected twice - fall 2025 (pre-test) and spring 2026 (post-test). Deaf children will complete three expressive language prompts representing major discourse types: personal narrative, informational report, and persuasive discourse. Their signed and written compositions will be analyzed using rubrics adapted from the National Assessment of Educational Progress (NAEP), focusing on growth in discourse-level skills.

The study hypothesizes that deaf children in the intervention group will show greater gains in expressive signing and writing than their peers in the control group. This hypothesis reflects the expectation that a systematic, discourse-oriented language intervention offers stronger support for language development than typical intervention routines.

This research aims to contribute to the evidence base on interventions that support deaf children's expressive language development. By examining child-level language outcomes from a discourse-focused intervention, the study will advance understanding of how structured language support can strengthen signing and writing development for deaf children.

02

Conditions studied

  • Sign Language Skills
  • Teacher Practice

Keywords

  • Deaf
  • Sign language
  • Instruction
  • Intervention
03

In context

Lead sponsor

The University of Tennessee, Knoxville is the lead sponsor of 95 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Deaf children in educational programs (aged 4-12)
  • Teachers of the deaf working with deaf children

Exclusion criteria

Exclusion Criteria:

  • Non-deaf children
  • Non teachers of the deaf
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    RCT - Experimental

    This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.

    Behavioral: Strategic and Interactive Signing Instruction

  • Placebo comparator
    Quasi-Experimental Study - Control

    This quasi-experimental study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.

    Behavioral: Business-As-Usual Instruction

Interventions

  • BehavioralStrategic and Interactive Signing Instruction

    Evidence-based instructional methods guided by cognitive, sociocultural, and linguistic theories that are applied to interventions supporting sign language development among deaf children.

  • BehavioralBusiness-As-Usual Instruction

    Teachers will teach business-as-usual without the inclusion of SISI.

06

What researchers measure

Primary outcomes

  1. Sign Language Skills

    Student data will be analyzed using rubrics adapted from the National Assessment of Educational Progress (NAEP) standardized writing assessments.

    Time frame: From enrollment to the end of treatment 9 academic months later.

  2. Teacher Practice

    The SISI Fidelity Tool, grounded in existing literature on evidence-based instructional methods, will be used to evaluate teachers' instructional practices.

    Time frame: From enrollment to the end of treatment 9 academic months later.

Secondary outcomes

  1. Written Language Skills

    Student data will be analyzed using rubrics adapted from the National Assessment of Educational Progress (NAEP) standardized writing assessments.

    Time frame: From enrollment to the end of treatment 9 academic months later.

07

Study locations

1 site
08

References and documents

Publications

  • Holcomb L, Eberwein AA. Teacher reports of ASL literacy instruction in deaf education. J Deaf Stud Deaf Educ. 2026 Jul 2;31(2):224-237. doi: 10.1093/jdsade/enaf060. PubMed 41055392 ↗
  • Holcomb L. Exploring signed literacy in elementary deaf students through evidence-based instructional methods. Sign Language Studies. 2024; 24(4):843-882.

Individual participant data

Plan to share: Yes — Under a data-sharing agreement that is in compliance with the internal policy at UTK, non-identifying data can be shared with other researchers for a minimum of 10 years on the University of Tennessee Research and Creative Exchange (TRACE). The raw data consists of videos of teachers, which will not be shared to maintain confidentiality. The processed data will be in the form of percentages for individual teachers across an academic year documented in a .csv file (Excel). Center for Open Science Foundation (OSF) is a free and open source project management tool that supports researchers throughout their entire project lifecycle. OSF also allows people to locate this data through project names, author names, and study keywords.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: December, 2026 to December, 2036

Access criteria: Researchers may contact the principal investigator for additional supporting information not available on OSF.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Sep 2026, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2024
First posted
Dec 11, 2024
StartActual
Apr 1, 2025
Primary completionEst.
Sep 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06729164
Lead sponsor
The University of Tennessee, Knoxville
Responsible party
Sponsor
First posted
Dec 11, 2024
Start date
Apr 1, 2025
Primary completion
Sep 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 28, 2026

Study contacts

Leala Holcomb, PhD
principal investigator · Center of Deafness

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion